- Home
- SONM vs TOVX Comparison
SONM vs TOVX Comparison
Compare SONM & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$4.37
N/A
Current Price
$0.18
Company Overview
Basic Information| Metric | SONM | TOVX |
|---|---|---|
| Founded | 1999 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 6.4M |
| IPO Year | 2019 | 2012 |
Fundamental Metrics
Financial Performance| Metric | SONM | TOVX |
|---|---|---|
| Price | $4.37 | $0.18 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.4K | ★ 6.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $58,298,000.00 | N/A |
| Revenue This Year | $127.68 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.52 | $0.16 |
| 52 Week High | $12.30 | $1.50 |
Technical Indicators
Market Signals| Indicator | SONM | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 36.45 | 45.66 |
| Support Level | $0.66 | $0.17 |
| Resistance Level | $7.08 | $0.26 |
| Average True Range (ATR) | 0.50 | 0.02 |
| MACD | -0.14 | -0.00 |
| Stochastic Oscillator | 0.00 | 20.48 |
Price Performance
Historical Comparison SONM
TOVX
About SONM Sonim Technologies Inc.
DNA X Inc operates a digital asset management platform.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.